High-Throughput Mutation Profiling of Primary and Metastatic Endometrial Cancers Identifies KRAS, FGFR2 and PIK3CA to Be Frequently Mutated

• Camilla Krakstad ,

  Contributed equally to this work with: Camilla Krakstad, Even Birkeland

  * E-mail: camilla.krakstad@med.uib.no

  Affiliations Department of Clinical Medicine, University of Bergen, Bergen, Norway, Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway

  ⨯
• Even Birkeland ,

  Contributed equally to this work with: Camilla Krakstad, Even Birkeland

  Affiliations Department of Clinical Medicine, University of Bergen, Bergen, Norway, Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway

  ⨯
• Danila Seidel,

  Affiliations Department of Translational Genomics, University of Cologne, Cologne, Germany, Max Planck Institute for Neurological Research, Cologne, Germany, Laboratory of Translational Cancer Genomics, Center of Integrated Oncology Köln – Bonn, University of Cologne, Cologne, Germany

  ⨯
• Kanthida Kusonmano,

  Affiliations Department of Clinical Medicine, University of Bergen, Bergen, Norway, Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway, Computational Biology Unit, Uni Computing, Uni Research AS, Bergen, Norway

  ⨯
• Kjell Petersen,

  Affiliation Computational Biology Unit, Uni Computing, Uni Research AS, Bergen, Norway

  ⨯
• Siv Mjøs,

  Affiliations Department of Clinical Medicine, University of Bergen, Bergen, Norway, Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway

  ⨯
• Erling A. Hoivik,

  Affiliations Department of Clinical Medicine, University of Bergen, Bergen, Norway, Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway

  ⨯
• Elisabeth Wik,

  Affiliations Department of Clinical Medicine, University of Bergen, Bergen, Norway, Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway

  ⨯
• Mari Kyllesø Halle,

  Affiliations Department of Clinical Medicine, University of Bergen, Bergen, Norway, Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway

  ⨯
• Anne M. Øyan,

  Affiliations The Gade Institute, University of Bergen, Bergen, Norway, Department of Microbiology, Haukeland University Hospital, Bergen, Norway

  ⨯
• Karl-Henning Kalland,

  Affiliations The Gade Institute, University of Bergen, Bergen, Norway, Department of Microbiology, Haukeland University Hospital, Bergen, Norway

  ⨯
• Henrica Maria Johanna Werner,

  Affiliations Department of Clinical Medicine, University of Bergen, Bergen, Norway, Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway

  ⨯
• Jone Trovik,

  Affiliations Department of Clinical Medicine, University of Bergen, Bergen, Norway, Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway

  ⨯
• Helga Salvesen

  Affiliations Department of Clinical Medicine, University of Bergen, Bergen, Norway, Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway

  ⨯